Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3819 | 1827 | 30.5 | 69% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ALMOTRIPTAN | Author keyword | 128 | 79% | 4% | 81 |
2 | SUMATRIPTAN | Author keyword | 121 | 36% | 15% | 269 |
3 | RIZATRIPTAN | Author keyword | 100 | 65% | 5% | 95 |
4 | TRIPTANS | Author keyword | 76 | 42% | 8% | 140 |
5 | ZOLMITRIPTAN | Author keyword | 76 | 57% | 5% | 91 |
6 | TRIPTAN | Author keyword | 57 | 47% | 5% | 90 |
7 | ELETRIPTAN | Author keyword | 47 | 66% | 2% | 43 |
8 | NARATRIPTAN | Author keyword | 26 | 52% | 2% | 35 |
9 | FROVATRIPTAN | Author keyword | 26 | 54% | 2% | 33 |
10 | HEADACHE RECURRENCE | Author keyword | 24 | 91% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALMOTRIPTAN | 128 | 79% | 4% | 81 | Search ALMOTRIPTAN | Search ALMOTRIPTAN |
2 | SUMATRIPTAN | 121 | 36% | 15% | 269 | Search SUMATRIPTAN | Search SUMATRIPTAN |
3 | RIZATRIPTAN | 100 | 65% | 5% | 95 | Search RIZATRIPTAN | Search RIZATRIPTAN |
4 | TRIPTANS | 76 | 42% | 8% | 140 | Search TRIPTANS | Search TRIPTANS |
5 | ZOLMITRIPTAN | 76 | 57% | 5% | 91 | Search ZOLMITRIPTAN | Search ZOLMITRIPTAN |
6 | TRIPTAN | 57 | 47% | 5% | 90 | Search TRIPTAN | Search TRIPTAN |
7 | ELETRIPTAN | 47 | 66% | 2% | 43 | Search ELETRIPTAN | Search ELETRIPTAN |
8 | NARATRIPTAN | 26 | 52% | 2% | 35 | Search NARATRIPTAN | Search NARATRIPTAN |
9 | FROVATRIPTAN | 26 | 54% | 2% | 33 | Search FROVATRIPTAN | Search FROVATRIPTAN |
10 | HEADACHE RECURRENCE | 24 | 91% | 1% | 10 | Search HEADACHE+RECURRENCE | Search HEADACHE+RECURRENCE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ORAL SUMATRIPTAN | 209 | 80% | 7% | 132 |
2 | SUMATRIPTAN | 126 | 29% | 20% | 362 |
3 | RIZATRIPTAN | 112 | 66% | 6% | 105 |
4 | SUBCUTANEOUS SUMATRIPTAN | 107 | 48% | 9% | 163 |
5 | TRIPTANS | 87 | 53% | 6% | 116 |
6 | ORAL ALMOTRIPTAN | 77 | 96% | 1% | 24 |
7 | MK 462 | 72 | 100% | 1% | 23 |
8 | 5 HT1B 1D AGONISTS | 71 | 62% | 4% | 73 |
9 | 311C90 | 60 | 68% | 3% | 52 |
10 | ORAL LYSINE ACETYLSALICYLATE | 47 | 86% | 1% | 24 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH | 4 | 13% | 1% | 27 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials | 2002 | 249 | 90 | 81% |
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force | 2009 | 176 | 191 | 40% |
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy | 2000 | 252 | 138 | 71% |
Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post-Discharge Medications | 2012 | 22 | 42 | 95% |
Guidelines for controlled trials of drugs in migraine: second edition | 2000 | 362 | 80 | 44% |
Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings | 2015 | 2 | 61 | 67% |
Rescue Therapy for Acute Migraine, Part 2: Neuroleptics, Antihistamines, and Others | 2012 | 21 | 51 | 88% |
Triptans for the Management of Migraine | 2010 | 40 | 45 | 76% |
Rescue Therapy for Acute Migraine, Part 1: Triptans, Dihydroergotamine, and Magnesium | 2012 | 19 | 54 | 70% |
Ketorolac in the Treatment of Acute Migraine: A Systematic Review | 2013 | 8 | 30 | 70% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KINGS HEADACHE SERV | 10 | 42% | 1.0% | 19 |
2 | HEADACHE CARE | 7 | 57% | 0.4% | 8 |
3 | GOTHENBURG MIGRAINE CLIN | 6 | 58% | 0.4% | 7 |
4 | SOCIALA HUSET | 5 | 63% | 0.3% | 5 |
5 | HEADACHE RIO | 4 | 67% | 0.2% | 4 |
6 | NEUROL PSYCHIAT THER EUT DEV GRP | 4 | 75% | 0.2% | 3 |
7 | WS3C 90 | 3 | 100% | 0.2% | 3 |
8 | WS3C90 | 3 | 100% | 0.2% | 3 |
9 | LEIDEN TRANSLAT NEUROSCI | 3 | 50% | 0.2% | 4 |
10 | BG CONSUMER CARE | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000264292 | MIGRAINE PROPHYLAXIS//MIGRAINE PREVENTION//HEADACHE CEREBROVASC |
2 | 0.0000244691 | MEDICATION OVERUSE HEADACHE//CHRONIC DAILY HEADACHE//CHRONIC MIGRAINE |
3 | 0.0000208880 | TRIGEMINOVASCULAR//HEADACHE GRP//CGRP RECEPTOR ANTAGONISTS |
4 | 0.0000205502 | MENSTRUAL MIGRAINE//MENSTRUALLY RELATED MIGRAINE//WOMENS HEADACHE |
5 | 0.0000146428 | ERGOTISM//IATROGENIC ERGOTISM//AFULA BRUCE R P ORT MED |
6 | 0.0000101511 | PEDIATRIC MIGRAINE//PEDMIDAS//PEDIATRIC HEADACHE |
7 | 0.0000094418 | 5 HT1D RECEPTOR//GR127935//5 HT MODULINE |
8 | 0.0000091631 | XANTHOCHROMIA//WARNING LEAK//PSEUDO SUBARACHNOID HEMORRHAGE |
9 | 0.0000061866 | MIGRAINE WITH AURA//SERV CLIN GOVERNANCE//MIGRAINOUS INFARCT |
10 | 0.0000051715 | CAS 17479 19 5//DECMER INTENS//CAS 14271 05 7 |